🛍️ The 52 best Walmart Black Friday deals to shop right now (updating) 🛍️ By Amber Dance/Knowable Magazine Published Jan 26, 2024 3:00 PM EST This article was originally featured on Knowable ...

研究背景 三维基因组互作与表观遗传修饰共同调控基因表达，其动态变化与细胞发育及疾病发生密切相关。测序技术和荧光原位杂交技术（FISH）已广泛用于该领域，但主要依赖固定细胞，难以捕捉染色质实时动态。基于CRISPR的活细胞成像方法可靶向内源基因，但在非重复序列，多位点成像及原代细胞中的应用难度较大。结果与展望 ...

近日，国际知名期刊 Journal of Infection 正式在线发表了军事科学院军事医学研究院李浩、孙岩松、冯烨团队的最新研究成果：“High-efficiency inhibition of human adenovirus type 55 ...

Deep-pocketed investors have adopted a bearish approach towards CRISPR Therapeutics (NASDAQ:CRSP), and it's something market players shouldn't ignore. Our tracking of public options records at ...

Crispr Therapeutics, a leader in CRISPR/Cas9 biotechnology, recently received FDA and EMA approval for Casgevy, the first CRISPR/Cas9-based treatment for TDT and SCD. The partnership with Vertex ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

We expect investors to focus on the sales performance of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other pipeline updates when the company reports its second-quarter 2025 results.

An acquisition could be both a blessing and a curse for long-term investors. Gene-therapy treatments are growing in popularity, and for a larger healthcare company that is perhaps looking into getting ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Crispr Therapeutics AG stock has plunged deep into a bear market. The FOMO attributed to Crispr's Casgevy approvals is likely dissipated. Crispr has an expanding early-stage portfolio. Crispr is also ...

You've probably heard about the gene-editing technology CRISPR. The massive biotech breakthrough, which has emerged in the last decade, has mainly been touted for the ways it will let scientists edit ...